Organogenesis Holdings (ORGO) Change in Inventory (2018 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Change in Inventory of $8.7 million for Q1 2026, little changed year-over-year from $8.7 million in Q1 2025, and up 194.83% quarter-over-quarter from $3.0 million in Q4 2025.
Organogenesis Holdings (ORGO) Change in Inventory (2018 - 2026) Analysis & Trends
Organogenesis Holdings' Change in Inventory history runs 9 years deep, the most recent figure standing at $8.7 million for Q1 2026.
- In Q1 2026, Change in Inventory changed 0.02% year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $17.9 million (up 74.49% YoY), while the FY2025 annual figure was $17.9 million, up 188.77% from the prior year.
- Change in Inventory for Q1 2026 stood at $8.7 million, up from $3.0 million in the prior quarter.
- The five-year high for Change in Inventory was $8.7 million in Q1 2025, with the low at -$2.7 million in Q2 2024.
- The 5-year median for Change in Inventory is $3.0 million (2025), against an average of $3.0 million.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory jumped 2803.75% in 2023, then slumped 241.39% in 2024.
- Organogenesis Holdings' Change in Inventory stood at $2.1 million in 2022, then plunged by 66.82% to $706000.0 in 2023, then slumped by 35.55% to $455000.0 in 2024, then jumped by 550.77% to $3.0 million in 2025, then surged by 194.83% to $8.7 million in 2026.
- Business Quant data shows ORGO's Change in Inventory at $8.7 million in Q1 2026, $3.0 million in Q4 2025, and -$938000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Organogenesis Holdings | 241.91 Mn | 195.06 Mn | 20.08 Mn | 3.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.08 Mn |
| Jun 30, 2026 | 3.08 Mn |
| Mar 31, 2026 | 8.73 Mn |
| Mar 31, 2026 | 8.73 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | -938,000.00 |
| Sep 30, 2025 | -938,000.00 |
| Jun 30, 2025 | 7.16 Mn |
| Jun 30, 2025 | 7.16 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Dec 31, 2024 | 455,000.00 |
| Dec 31, 2024 | 455,000.00 |
| Sep 30, 2024 | 3.74 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Mar 31, 2024 | 4.67 Mn |
| Mar 31, 2024 | 4.67 Mn |